Application of PPARα transgenic mice in the evaluation of drug toxicity
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To explore whether PPARα transgenic mice are more sensitive animal models in the evaluation of toxicity of PPARα agonists. Methods Twenty-eight 8-week old PPARα transgenic mice (Tg) and 28 C57BL/6J mice (WT) with half males and half females were randomly divided into high dose group (400 mg/kg of clofibrate), low dose group (30 mg/kg of clofibrate) and solvent control group (10% sodium carboxymethyl cellulose). The time of gavage administration lasted 28 days. The blood biochemistry, organ coefficient and pathological changes of the heart, liver, kidney were tested after the drug administration.The growth of mice was also recorded.Results ①Blood biochemistry: Compared with the WT male administration group, in the Tg male administration group, the levels of blood creatinine (CREA) and aspartate aminotransferase (AST) were markedly increased (P<0.01, P<0.05). ② Organ coefficient: Compared with the Tg control group, the kidney coefficients of Tg administration group were significantly increased(P<0.01,P<0.05). ③Histopathology:Compared with the WT administration group, the pathological damages of liver and kidney were more serious in the Tg administration group. Conclusions Compared with C57BL/6J mouse, PPARα transgenic mice are more sensitive in evaluation of hepatotoxicity and nephrotoxicity of PPARα agonists.It is a new animal model.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 06,2015
  • Revised:
  • Adopted:
  • Online: June 30,2015
  • Published: